{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:42:53Z","timestamp":1789954973943,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ejim.2016.03.010","type":"journal-article","created":{"date-parts":[[2016,4,7]],"date-time":"2016-04-07T10:06:44Z","timestamp":1460023604000},"page":"65-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Mutation detection rates associated with specific selection criteria for BRCA1\/2 testing in 1854 high-risk families: A monocentric Italian study"],"prefix":"10.1016","volume":"32","author":[{"given":"Jacopo","family":"Azzollini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulietta","family":"Scuvera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Pasanisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Zaffaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Calvello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Pasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla B.","family":"Ripamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Pensotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Radice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Peissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siranoush","family":"Manoukian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2016.03.010_bb0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1399-0004.2012.01859.x","article-title":"Familial breast cancer","volume":"82","author":"Lalloo","year":"2012","journal-title":"Clin Genet"},{"key":"10.1016\/j.ejim.2016.03.010_bb0010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12687-011-0042-4","article-title":"Genetic testing for familial\/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, The Netherlands and Germany","volume":"2","author":"Gadzicki","year":"2011","journal-title":"J Community Genet"},{"key":"10.1016\/j.ejim.2016.03.010_bb0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/M13-2747","article-title":"U.S. Preventive Services Task Force. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2016.03.010_bb0020","first-page":"1730","article-title":"Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility","volume":"14","author":"American Society of Clinical Oncology","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejim.2016.03.010_bb0025","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/humu.20880","article-title":"IARC Unclassified Genetic Variants Working Group. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results","volume":"29","author":"Plon","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ejim.2016.03.010_bb0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ng0197-103","article-title":"Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene","volume":"15","author":"Gayther","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2016.03.010_bb0035","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jama.2014.5985","article-title":"Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer","volume":"313","author":"Rebbeck","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2016.03.010_bb0045","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.breast.2013.07.053","article-title":"Performance of BOADICEA and BRCAPRO genetic models and of empirical criteria based on cancer family history for predicting BRCA mutation carrier probabilities: a retrospective study in a sample of Italian cancer genetics clinics","volume":"22","author":"Varesco","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.ejim.2016.03.010_bb0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2011.01.020","article-title":"Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer","volume":"121","author":"Zhang","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejim.2016.03.010_bb0055","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group","volume":"30","author":"Alsop","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejim.2016.03.010_bb0060","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1093\/hmg\/ddu172","article-title":"The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population","volume":"23","author":"Song","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejim.2016.03.010_bb0065","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1002\/ijc.28875","article-title":"Validation of the Manchester scoring system for predicting BRCA1\/2 mutations in 9,390 families suspected of having hereditary breast and ovarian cancer","volume":"135","author":"Kast","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejim.2016.03.010_bb0070","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ijc.1626","article-title":"German consortium for hereditary breast and ovarian cancer. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population","volume":"97","author":"Meindl","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejim.2016.03.010_bb0075","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.clon.2010.11.007","article-title":"The Korean Hereditary Breast Cancer (KOHBRA) study: protocols and interim report","volume":"23","author":"Han","year":"2011","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ejim.2016.03.010_bb0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10549-011-1544-9","article-title":"Prevalence of BRCA1\/2 mutations in sporadic breast\/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing","volume":"132","author":"De Leeneer","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejim.2016.03.010_bb0085","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10549-014-3167-4","article-title":"Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers","volume":"148","author":"Zugazagoitia","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejim.2016.03.010_bb0090","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","article-title":"Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer","volume":"33","author":"Couch","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejim.2016.03.010_bb0095","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10549-012-2062-0","article-title":"Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy","volume":"134","author":"Ottini","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejim.2016.03.010_bb0100","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1002\/cncr.27556","article-title":"Clinical significance of large rearrangements in BRCA1 and BRCA2","volume":"118","author":"Judkins","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ejim.2016.03.010_bb0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10549-010-0853-8","article-title":"Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics","volume":"124","author":"Zuradelli","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejim.2016.03.010_bb0110","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/PPO.0000000000000057","article-title":"Adverse events in cancer genetic testing: the third case series","volume":"20","author":"Bonadies","year":"2014","journal-title":"Cancer J"},{"key":"10.1016\/j.ejim.2016.03.010_bb0115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2217\/14796694.2.2.257","article-title":"Risk prediction models for familial breast cancer","volume":"2","author":"Antoniou","year":"2006","journal-title":"Future Oncol"},{"key":"10.1016\/j.ejim.2016.03.010_bb0120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10689-014-9766-8","article-title":"Estimate of the penetrance of BRCA mutation and the COS software for the assessment of BRCA mutation probability","volume":"14","author":"Berrino","year":"2015","journal-title":"Fam Cancer"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620516300309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620516300309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T15:51:57Z","timestamp":1536853917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620516300309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":23,"alternative-id":["S0953620516300309"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2016.03.010","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutation detection rates associated with specific selection criteria for BRCA1\/2 testing in 1854 high-risk families: A monocentric Italian study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2016.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}